Total Payments
$5,393
2024 Payments
$616.01
Companies
41
Transactions
347
Medicare Patients
1,695
Medicare Billing
$56,676
Payment Breakdown by Category
Food & Beverage$3,518 (65.2%)
Research$1,275 (23.6%)
Education$356.68 (6.6%)
Gifts$228.45 (4.2%)
Consulting$15.29 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,518 | 211 | 65.2% |
| Unspecified | $1,275 | 3 | 23.6% |
| Education | $356.68 | 8 | 6.6% |
| Gift | $228.45 | 124 | 4.2% |
| Consulting Fee | $15.29 | 1 | 0.3% |
Payments by Type
General
$4,118
344 transactions
Research
$1,275
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $1,365 | 8 | $0 (2018) |
| ASCEND THERAPEUTICS US, LLC | $586.67 | 155 | $0 (2023) |
| ABBVIE INC. | $404.34 | 17 | $0 (2023) |
| PFIZER INC. | $324.07 | 38 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $287.37 | 12 | $0 (2020) |
| Exeltis, USA Inc. | $269.50 | 15 | $0 (2024) |
| Astellas Pharma US Inc | $269.25 | 17 | $0 (2024) |
| Fisher Scientific Company L.L.C. | $257.89 | 1 | $0 (2024) |
| Organon Llc | $156.78 | 8 | $0 (2024) |
| Amgen Inc. | $136.71 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $616.01 | 23 | Fisher Scientific Company L.L.C. ($257.89) |
| 2023 | $744.98 | 44 | ASCEND THERAPEUTICS US, LLC ($234.29) |
| 2022 | $551.75 | 59 | ASCEND Therapeutics US, LLC ($117.03) |
| 2021 | $161.88 | 7 | Minerva Surgical, Inc ($46.33) |
| 2020 | $123.67 | 7 | Bayer HealthCare Pharmaceuticals Inc. ($53.33) |
| 2019 | $566.40 | 30 | Merck Sharp & Dohme Corporation ($160.86) |
| 2018 | $783.09 | 123 | ASCEND Therapeutics US, LLC ($221.15) |
| 2017 | $1,846 | 54 | Allergan Inc. ($1,341) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: CONTRACEPTIVE | ||||||
| 12/09/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: ETONOGESTREL | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Biological | ||||||
| 10/16/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Biological | ||||||
| 09/26/2024 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Education | In-kind items and services | $257.89 | General |
| Category: Infectious Disease | ||||||
| 09/23/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: WOMENS HEALTH | ||||||
| 08/19/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: VACCINES | ||||||
| 08/15/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Hematology | ||||||
| 08/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Biological | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Biological | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $0.22 | General |
| Category: Biological | ||||||
| 05/08/2024 | Organon Llc | — | Food and Beverage | In-kind items and services | $17.78 | General |
| 05/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Biological | ||||||
| 05/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $0.27 | General |
| Category: Biological | ||||||
| 05/02/2024 | Organon Llc | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 04/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Biological | ||||||
| 03/19/2024 | Gynesonics, Inc. | SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM | ||||||
| 03/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Biological | ||||||
| 02/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Biological | ||||||
| 02/12/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: ETONOGESTREL | ||||||
| 01/22/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: HORMONE THERAPY | ||||||
| 01/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Biological | ||||||
| 12/11/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.77 | General |
| Category: Women's Health | ||||||
| 12/04/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Biological | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ULIPRISTAL ACETATE FOR THE INTERMITTENT TREATMENT OF ABNORMAL UTERINE BLEEDING ASSOCIATED WITH LEIOMYOMAS | Allergan Inc. | $1,275 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 353 | 373 | $33,618 | $11,787 |
| 2022 | 6 | 357 | 372 | $32,670 | $11,671 |
| 2021 | 7 | 497 | 530 | $49,048 | $17,749 |
| 2020 | 7 | 488 | 505 | $45,260 | $15,470 |
Total Patients
1,695
Total Services
1,780
Medicare Billing
$56,676
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 47 | $9,682 | $3,856 | 39.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 82 | 82 | $10,742 | $3,556 | 33.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 88 | 88 | $9,768 | $3,415 | 35.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 30 | 30 | $2,040 | $530.70 | 26.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 116 | 126 | $1,386 | $429.66 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 39 | $8,034 | $3,497 | 43.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 72 | 72 | $8,119 | $2,830 | 34.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 59 | 59 | $7,729 | $2,580 | 33.4% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 86 | 86 | $5,848 | $1,532 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $1,807 | $878.34 | 48.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 97 | 103 | $1,133 | $353.45 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 52 | $9,113 | $4,834 | 53.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 101 | 101 | $8,751 | $4,001 | 45.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 89 | 89 | $8,487 | $3,907 | 46.0% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 18 | 20 | $7,108 | $1,863 | 26.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 100 | 100 | $8,362 | $1,805 | 21.6% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 21 | 21 | $5,250 | $826.98 | 15.8% |
| 81002 | Urinalysis, manual test | Office | 2021 | 131 | 147 | $1,977 | $511.56 | 25.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 95 | 95 | $6,650 | $3,828 | 57.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 79 | 79 | $5,530 | $3,474 | 62.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 44 | $7,260 | $2,958 | 40.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 114 | 114 | $10,260 | $2,048 | 20.0% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 15 | 16 | $5,450 | $1,399 | 25.7% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 33 | 33 | $8,250 | $1,333 | 16.2% |
| 81002 | Urinalysis, manual test | Office | 2020 | 119 | 124 | $1,860 | $429.63 | 23.1% |
About Dr. Clark Griffith, M.D
Dr. Clark Griffith, M.D is a Obstetrics & Gynecology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588666242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clark Griffith, M.D has received a total of $5,393 in payments from pharmaceutical and medical device companies, with $616.01 received in 2024. These payments were reported across 347 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($3,518).
As a Medicare-enrolled provider, Griffith has provided services to 1,695 Medicare beneficiaries, totaling 1,780 services with total Medicare billing of $56,676. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Dallas, TX
- Active Since 08/12/2005
- Last Updated 02/10/2022
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1588666242
Products in Payments
- ESTROGEL (Drug) $449.89
- NEXPLANON (Drug) $322.81
- Procalcitonin (Device) $257.89
- Veozah (Drug) $238.80
- PREMARIN (Drug) $179.39
- Lupron (Drug) $151.60
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) $135.69
- SLYND (Drug) $135.35
- LO LOESTRIN FE (Drug) $123.66
- Kyleena (Drug) $120.50
- Orilissa (Drug) $115.73
- MYFEMBREE (Drug) $103.38
- PREMARIN ORALS (Drug) $99.17
- DIVIGEL (Drug) $95.86
- Vitafol Ultra (Drug) $93.29
- INTRAROSA (Drug) $79.42
- EVENITY (Biological) $74.01
- NUVARING (Drug) $71.85
- MAKENA (Drug) $71.49
- ORILISSA (Drug) $64.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Dallas
Dustin Manders, Md, MD
Obstetrics & Gynecology — Payments: $141,025
Obstetrics & Gynecology $141,025
Dr. Yolanda Lawson, M.d, M.D
Obstetrics & Gynecology — Payments: $106,589
Obstetrics & Gynecology $106,589
Thomas Heffernan, Md, MD
Obstetrics & Gynecology — Payments: $106,510
Obstetrics & Gynecology $106,510
Dr. Kamilia Smith, M.d, M.D
Obstetrics & Gynecology — Payments: $89,030
Obstetrics & Gynecology $89,030
Satin Patel, M.d, M.D
Obstetrics & Gynecology — Payments: $54,616
Obstetrics & Gynecology $54,616
Quanita Crable, Md, MD
Obstetrics & Gynecology — Payments: $45,700
Obstetrics & Gynecology $45,700